Clinical Trial Update: Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia [NA]

View source ↗

Summary

This entry describes a clinical trial evaluating a gene-modified autologous hematopoietic stem cell therapy for transfusion-dependent beta-thalassemia and indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• Gene-modified autologous hematopoietic stem cell therapy (gene-modified autologous hematopoietic stem cells)

Snippet

Sponsor: Shanghai BDgene Co., Ltd. | Conditions: β-thalassemia Major | NA | Status: RECRUITING